Corrado, F., Bidikian, N., Bosch-Vilaseca, A., Konishi, Y., Toenges, R., Alberge, J., Wu, T., Magidson, S., Pantano, L., Aranha, M., Lightbody, E., Flinn, J., Timonian, M., Santos, D. C. D., Oca, R. M. D., Lengil, T., Vieyra, D., Wildgust, M., Plaks, V., Wiest, D. D., Braganca, K. D., Midha, S., O'Donnell, E., Liu, Y., Sturtevant, A., Anderson, K., Munshi, N., Ritz, J., Nadeem, O., Getz, G., Sklavenitis-Pistofidis, R., Ghobrial, I. (2025). Single-cell immune profiling reveals enhanced immune fitness of endogenous and engineered T cells in patients with high-risk smoldering myeloma compared to Relapsed/Refractory myeloma following bispecific antibodies or CAR-T cell therapies.. Blood. https://doi.org/10.1182/blood-2025-921